ELLIPTIC LABORATORIES ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11 NOK | -0.90% |
|
+8.70% | -35.45% |
| 07:00am | Elliptic Labs Launching on Transsion?S Infinix Note 40S Smartphone | CI |
| Jul. 03 | Elliptic Labs Expands Deal to Roll Out AI Sensor to More Laptops | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,208 | 2,882 | 2,295 | 1,786 | 1,168 | - |
| Enterprise Value (EV) 1 | 1,208 | 2,681 | 2,129 | 1,697 | 1,116 | 1,112 |
| P/E ratio | -9 x | -252 x | -71.1 x | -47.3 x | 61.7 x | 9.91 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 27 x | 45.7 x | 44.1 x | 26.1 x | 7.61 x | 3.35 x |
| EV / Revenue | 27 x | 42.5 x | 40.9 x | 24.8 x | 7.26 x | 3.19 x |
| EV / EBITDA | - | -948 x | -69.1 x | -50.6 x | 27.8 x | 6.02 x |
| EV / FCF | - | -94,277,852 x | -59,008,572 x | - | - | - |
| FCF Yield | - | -0% | -0% | - | - | - |
| Price to Book | - | 8.41 x | 7.04 x | 5.82 x | 3.56 x | 2.55 x |
| Nbr of stocks (in thousands) | 95,846 | 103,842 | 104,074 | 104,838 | 105,269 | - |
| Reference price 2 | 12.60 | 27.75 | 22.05 | 17.04 | 11.10 | 11.10 |
| Announcement Date | 4/21/21 | 3/10/22 | 2/17/23 | 2/15/24 | - | - |
1NOK in Million2NOK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 44.73 | 63.04 | 52.06 | 68.32 | 153.6 | 348.3 |
| EBITDA 1 | - | -2.829 | -30.81 | -33.52 | 40.06 | 184.7 |
| EBIT 1 | - | -11.14 | -42.13 | -49.74 | 19.76 | 160.5 |
| Operating Margin | - | -17.67% | -80.92% | -72.81% | 12.86% | 46.07% |
| Earnings before Tax (EBT) 1 | - | -13.09 | -39.3 | -46.86 | 24.13 | 164.8 |
| Net income 1 | - | -11.16 | -32.04 | -37.85 | 19.98 | 128.6 |
| Net margin | - | -17.7% | -61.54% | -55.4% | 13.01% | 36.91% |
| EPS 2 | -1.400 | -0.1100 | -0.3100 | -0.3600 | 0.1800 | 1.120 |
| Free Cash Flow | - | -28.43 | -36.08 | - | - | - |
| FCF margin | - | -45.11% | -69.31% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 4/21/21 | 3/10/22 | 2/17/23 | 2/15/24 | - | - |
1NOK in Million2NOK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 201 | 166 | 89.7 | 52.9 | 56.4 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -28.4 | -36.1 | - | - | - |
| ROE (net income / shareholders' equity) | - | -4.2% | -9.7% | -12% | 6.34% | 33.2% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 3.300 | 3.130 | 2.930 | 3.120 | 4.350 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 17.6 | 23.3 | 25.5 | 27.9 | 33.2 |
| Capex / Sales | - | 27.94% | 44.81% | 37.29% | 18.17% | 9.54% |
| Announcement Date | 4/21/21 | 3/10/22 | 2/17/23 | 2/15/24 | - | - |
1NOK in Million2NOK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
11.1
NOK
Average target price
22
NOK
Spread / Average Target
+98.20%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -35.45% | 111M | |
| -10.45% | 29.99B | |
| +29.55% | 12.11B | |
| +15.05% | 5.59B | |
| +30.27% | 1.31B | |
| +52.79% | 514M | |
| -11.57% | 450M | |
| -28.13% | 358M | |
| -31.42% | 213M | |
| -38.85% | 209M |
- Stock Market
- Equities
- ELABS Stock
- Financials Elliptic Laboratories ASA
